Detection and significance of biofilm formation in yeasts isolated from haemocultures;Detekce a význam tvorby biofilmu u kvasinek izolovaných z hemokultur

Klinicka Mikrobiologie a Infekcni Lekarstvi

Volumn 12, Issue 4, 2006, Pages 150-153

  Růžička, Filip ^a   Hola F V ^a   Votava, M ^a   Tejkalova R ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Biofilm; Candida; Yeast

Indexed keywords

ANTIFUNGAL AGENT; VIRULENCE FACTOR;

ARTICLE; BIOFILM; BLOOD CULTURE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CATHETER INFECTION; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; INFECTION RISK; MICROTITER PLATE ASSAY; MYCOSIS; NONHUMAN; SEPTICEMIA; YARROWIA LIPOLYTICA; YEAST;

BIOFILMS; BLOOD; CANDIDA; CULTURE MEDIA; HUMANS;

EID: 33749079617     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Pfaller MA, Jones RN, Doern GV et. Al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 2000;44747-51.
2. Kontoyiannis DP, Vaziri I, Hanna HA, et al. Risk Factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 2001;33:1676-81.
3. Viudes A, Peman J, Canton E, et al. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis 2002;21:767-74.
4. Tomíška M, Burgetová D, Ráčil Z, Adam Z. Léčba infekcí u pacientů s maligními chorobami. In Adam Z, Vorlíček J, Koptíková J (eds): Obecná onkologie a podpůrná léčba. Praha, Grada Publishing, 2003:437-88.
5. Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 1994;62:915-21.
6. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004;17:255-67.
7. Raad I. Intravascular-catheter-related infections. Lancet 1998;351:893-98.
8. Baillie GS, Douglas LJ. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol 1999;310:644-56.
9. Ramage G, Wickes BL, Lopez-Ribot JL. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab 2001;20:42-44.
10. Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000;46:397-403.
11. Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001;183:5385-94.
12. Shin JH, Kee SJ, Shin MG, et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 2002;40:1244-48.
13. Ramage G, VandeWalle K, Lopez-Ribot JL, Wickes BL. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 2002;27: 95-100.
14. Sundstrom P. Adhesins in Candida albicans. Curr Opin Microbiol 1999;2:353-57.
15. Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun 1982;37:318-26.
16. Christensen GD, Simpson WA, Younger JJ, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985;22:996-1006.
17. Branchini ML, Pfaller MA, Rhine-Chalberg J, et al. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994;32:452-56.
18. Krcmery V, Kovacicova G. Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Slovak Fungaemia study group. Diagn Microbiol Infect Dis 2000,36:7-11.
19. Kumamoto CA. Candida biofilms. Curr Opin Microbiol 2002;5:608-11.
20. Kuhn DM, George T, Chandra J, et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin Blipid formulations and echinocandins. Antimicrob Agents Chemother 2002;46:1773-80.
21. Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000;30:662-78.
22. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249-72.